HOME > NEWS > Cristina Díaz

Cristina Díaz

Interview to Dr Cristina Díaz, researcher with the GEMAT group at the IQS School of Engineering.
Dra. Cristina Díaz
Dr Cristina Díaz, researcher with the GEMAT group at the IQS School of Engineering

1.What do you like most about your job?
Being able to make the projects we come up with a reality. After spending months drafting projects, proposing alternative strategies, and addressing any obstacles that arise, you finally get to do the experiments and see the results turn out the way they should (although not always at first). Going from the idea to reality is tremendously satisfying.

2. What would you like to spend more time doing?
Painting and sports. And spending more time with family and friends of course.

3. What do you feel proudest of?
I’m proudest of how far I’ve come professionally and being able to do a job that I enjoy and in which I can still learn things and grow more as a person.

4. What value do you appreciate most in people?
Sincerity and empathy.

5. Where’s a place you’d like to visit?
Somewhere out in the middle of nature or by the sea, listening to the birds chirping or the waves and disconnecting from busy city life.

6. What’s a dream you’d like to pursue?
I’d like to travel somewhere I haven’t been yet like India, Japan, or Australia.

7. What do you have left to learn?
Many things: knowledge is infinite. Working in research helps me learn new things every day.




Grup d'Enginyeria de Materials

School of Engineering

Materials Engineering

Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.



School of Engineering

Chemical & Synthetic Biology for Biotherapies

This group combines chemistry and synthetic biology to develop precision bio-nano-therapeutics based on smart proteins and to generate molecular systems that enable transport of therapeutics to the brain.


ADC2GBM (Development of brain-permeable masked nanobody-drug conjugates to eliminate glioma stem cells)

Innovative formulation to treat glioma using brain-permeable masked nanobody-drug conjugates.
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)